Anemia in Neurodegenerative Disorders: Implications for Cognitive Decline and Disease Progression

Anemia, a hematological disorder characterized by reduced hemoglobin levels or erythrocyte count, has gained increasing attention as a potential risk factor for neurodegenerative diseases, including Alzheimer’s disease (AD), Parkinson’s disease (PD), and multiple sclerosis (MS). Emerging evidence suggests that the systemic consequences of anemia, such as impaired oxygen delivery, increased oxidative stress, and dysregulated iron metabolism, may play a crucial role in the pathophysiology of neurodegeneration. Hypoxia-induced neuronal stress, mitochondrial dysfunction, and neuroinflammation are among the key pathways through which anemia may contribute to synaptic dysfunction, neuronal loss, and progressive cognitive impairment. This review comprehensively examines the mechanistic links between anemia and neurodegeneration, highlighting molecular and cellular pathways involved in anemia-associated neuronal injury. We also evaluate clinical and epidemiological studies that establish correlations between anemia and the onset or progression of neurodegenerative diseases, addressing potential confounding factors and variations across populations. Furthermore, we discuss current and emerging therapeutic strategies aimed at mitigating anemia-induced neurodegenerative changes, including iron supplementation, erythropoiesis-stimulating agents, and novel pharmacological approaches targeting oxidative stress and inflammation. Understanding the complex interplay between anemia and neurodegeneration may open new avenues for early diagnosis, risk stratification, and therapeutic interventions in vulnerable populations. By bridging the gap between hematological and neurological research, this review aims to provide a comprehensive perspective on the potential role of anemia as a modifiable factor in neurodegenerative disease management. Keywords: Anemia, Neurodegenerative Disorders, Cognitive Decline, Alzheimer’s Disease, Parkinson’s Disease, Oxidative Stress, Neuroinflammation, Iron Deficiency

Publication Details

Journal
NEWPORT INTERNATIONAL JOURNAL OF RESEARCH IN MEDICAL SCIENCES
Published
2025-05-04
DOI
https://doi.org/10.59298/nijrms/2025/6.2.4752
Primary Topic
Neurological diseases and metabolism
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Anemia in Neurodegenerative Disorders: Implications for Cognitive Decline and Disease Progression

NEWPORT INTERNATIONAL JOURNAL OF RESEARCH IN MEDICAL SCIENCES
Neurological diseases and metabolism
article

Anemia in Neurodegenerative Disorders: Implications for Cognitive Decline and Disease Progression

article en

Abstract

Anemia, a hematological disorder characterized by reduced hemoglobin levels or erythrocyte count, has gained increasing attention as a potential risk factor for neurodegenerative diseases, including Alzheimer’s disease (AD), Parkinson’s disease (PD), and multiple sclerosis (MS). Emerging evidence suggests that the systemic consequences of anemia, such as impaired oxygen delivery, increased oxidative stress, and dysregulated iron metabolism, may play a crucial role in the pathophysiology of neurodegeneration. Hypoxia-induced neuronal stress, mitochondrial dysfunction, and neuroinflammation are among the key pathways through which anemia may contribute to synaptic dysfunction, neuronal loss, and progressive cognitive impairment. This review comprehensively examines the mechanistic links between anemia and neurodegeneration, highlighting molecular and cellular pathways involved in anemia-associated neuronal injury. We also evaluate clinical and epidemiological studies that establish correlations between anemia and the onset or progression of neurodegenerative diseases, addressing potential confounding factors and variations across populations. Furthermore, we discuss current and emerging therapeutic strategies aimed at mitigating anemia-induced neurodegenerative changes, including iron supplementation, erythropoiesis-stimulating agents, and novel pharmacological approaches targeting oxidative stress and inflammation. Understanding the complex interplay between anemia and neurodegeneration may open new avenues for early diagnosis, risk stratification, and therapeutic interventions in vulnerable populations. By bridging the gap between hematological and neurological research, this review aims to provide a comprehensive perspective on the potential role of anemia as a modifiable factor in neurodegenerative disease management. Keywords: Anemia, Neurodegenerative Disorders, Cognitive Decline, Alzheimer’s Disease, Parkinson’s Disease, Oxidative Stress, Neuroinflammation, Iron Deficiency

NEWPORT INTERNATIONAL JOURNAL OF RESEARCH IN MEDICAL SCIENCESVol. 6(2)
Openalex Percentile: Top 87%
Neurological diseases and metabolism
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Anemia in Neurodegenerative Disorders: Implications for Cognitive Decline and Disease Progression · NEWPORT INTERNATIONAL JOURNAL OF RESEARCH IN MEDICAL SCIENCES (2025) | TGRS Research Map | TGRS